Average cost per year*
Average cost per beneficiary*
Bafiertam is a prescription medication used to manage certain neurological conditions, such as multiple sclerosis (MS). It contains monomethyl fumarate and helps reduce the frequency of relapses and slow down disease progression. While Bafiertam can be effective in managing MS, it does not provide a cure. To achieve optimal outcomes and minimize potential side effects, take Bafiertam as directed by your healthcare provider. Regular monitoring and follow-up are essential during treatment. This summary offers a general overview and may not encompass all available information about the product. It does not guarantee the product's safety, effectiveness, or suitability for your individual situation. Consult your healthcare professional for comprehensive information and individualized recommendations.
Yes, Bafiertam is covered by Medicare.
In 2021, the average cost per dose of Bafiertam was $49.21.
The average dose of Bafiertam received per year is 3,120 units
39 Medicare beneficiaries received Bafiertam in 2021
There were 112 claims made by Medicare beneficiaries
The average spending amount per claim in 2021 was $6,854.56
The average Medicare spending per beneficiary amount for Bafiertam was $19,684.88
Banner Life Sci received $767,710.26
The total amount spent on Bafiertam by Medicare is $767,710.26
*Origin of the terms and chart data used within this page: https://data.cms.gov/
Short Term Medical Insurance
Limited Fixed Indemnity Plans